 The purpose of this study to evaluate the effect of concomitant administration of GBT440 on caffeine a CYP1A2 probe substrate, S warfarin a CYP2C9 probe substrate, omeprazole a CYP2C19 probe substrate, and midazolam a CYP3A4 probe substrate plasma concentrations. 